Treatment of diabetic rodent models with α-MSH suppresses the retinopathy and also suppresses the extent of retinal damage caused by central vein occlusion in diabetic stroke mice models [21,24,25,43]. The gene discussed is STAMBP; the disease is retinal disorder.